{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:16:11Z","timestamp":1764656171068,"version":"3.41.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>VITT is a rare, life-threatening syndrome characterized by thrombotic symptoms in combination with thrombocytopenia, which may occur in individuals receiving the first administration of adenoviral non replicating vectors (AVV) anti Covid19 vaccines. Vaccine-induced immune thrombotic thrombocytopenia (VITT) is characterized by high levels of serum IgG that bind PF4\/polyanion complexes, thus triggering platelet activation. Therefore, identification of the fine pathophysiological mechanism by which vaccine components trigger platelet activation is mandatory. Herein, we propose a multistep mechanism involving both the AVV and the neo-synthetized Spike protein. The former can: i) spread rapidly into blood stream, ii), promote the early production of high levels of IL-6, iii) interact with erythrocytes, platelets, mast cells and endothelia, iv) favor the presence of extracellular DNA at the site of injection, v) activate platelets and mast cells to release PF4 and heparin. Moreover, AVV infection of mast cells may trigger aberrant inflammatory and immune responses in people affected by the mast cell activation syndrome (MCAS). The pre-existence of natural antibodies binding PF4\/heparin complexes may amplify platelet activation and thrombotic events. Finally, neosynthesized Covid 19 Spike protein interacting with its ACE2 receptor on endothelia, platelets and leucocyte may trigger further thrombotic events unleashing the WITT syndrome.<\/jats:p>","DOI":"10.3389\/fimmu.2021.728513","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T14:29:28Z","timestamp":1628864968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal"],"prefix":"10.3389","volume":"12","author":[{"given":"Bruno","family":"Azzarone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Veneziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (Covid-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2003.03011","article-title":"Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (Covid-19)","volume":"30","author":"Ahn","year":"2020","journal-title":"J Microbiol Biotechnol"},{"key":"B3","unstructured":""},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia After Chadox1 Ncov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2016-0070","article-title":"Simian Adenoviruses as Vaccine Vectors","volume":"11","author":"Morris","year":"2016","journal-title":"Future Virol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-021-10599-2","article-title":"Immediate High-Dose Intravenous Immunoglobulins Followed by Direct Thrombin-Inhibitor Treatment Is Crucial for Survival in Sars-Covid-19-Adenoviral Vector Vaccine-Induced Immune Thrombotic Thrombocytopenia Vitt With Cerebral Sinus Venous and Portal Vein Thrombosis","volume":"22","author":"Graf","year":"2021","journal-title":"J Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia After Chadox1 Ncov-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 After Chadox1 Ncov-19 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/vaccines9060559","article-title":"Thrombotic Thrombocytopenia After Covid-19 Vaccination: In Search of the Underlying Mechanism","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7326\/L21-0244","article-title":"Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine","volume":"29","author":"Sangli","year":"2021","journal-title":"Ann Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1026625","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (Vitt) Compared to Natural Sars-Cov-2 Infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J Autoimmun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1571307","article-title":"Platelet Function Tests in Bleeding Disorders","volume":"42","author":"Lassila","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302347","article-title":"Evaluation of Toxicity From High-Dose Systemic Administration of Recombinant Adenovirus Vector in Vector-Naive and Pre-Immunized Mice","volume":"12","author":"Varnavski","year":"2005","journal-title":"Gene Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-Induced Thrombocytopenia: The Role of Von Willebrand Factor and P-Selectin in Mediating Accelerated Platelet Clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02819-06","article-title":"Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver","volume":"81","author":"Stone","year":"2007","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-2254(199909\/10)1:5<360::AID-JGM54>3.0.CO;2-Q","article-title":"Intravenous Administration of Recombinant Adenoviruses Causes Thrombocytopenia, Anemia and Erythroblastosis in Rabbits","volume":"1","author":"Cichon","year":"1999","journal-title":"J Gene Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0347-7","article-title":"Coxsackievirus and Adenovirus Receptor Mediates the Responses of Endothelial Cells to Fluid Shear Stress","volume":"51","author":"Chung","year":"2019","journal-title":"Exp Mol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of Innate Immunity in Nonhuman Primates Following Intraportal Administration of Adenoviral Vectors","volume":"3","author":"Schnell","year":"2001","journal-title":"Mol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/10430340152712665","article-title":"Toxicity of a First-Generation Adenoviral Vector in Rhesus Macaques","volume":"13","author":"Lozier","year":"2002","journal-title":"Hum Gene Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04719.x","article-title":"Intravenous Administration of Replication-Incompetent Adenovirus to Rhesus Monkeys Induces Thrombocytopenia by Increasing in Vivo Platelet Clearance","volume":"123","author":"Wolins","year":"2003","journal-title":"Br J Haematol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12879-018-3651-2","article-title":"Human Adenovirus Type 7 Infection Causes a More Severe Disease Than Type 3","volume":"19","author":"Fu","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1086\/514978","article-title":"Disseminated Adenovirus Disease in Immunocompromised and Immunocompetent Children","volume":"27","author":"Munoz","year":"1998","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.11.004","article-title":"Clinical and Molecular Features of Adenovirus Type 2, 3, and 7 Infections in Children in an Outbreak in Taiwan, 2011","volume":"23","author":"Lin","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/v12121351","article-title":"Adenovirus-Extracellular Protein Interactions and Their Impact on Innate Immune Responses by Human Mononuclear Phagocytes","volume":"12","author":"Cheneau","year":"2020","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199703)51:3<182::AID-JMV7>3.0.CO;2-2","article-title":"Detection of Adenovirus DNA in Peripheral Blood Mononuclear Cells by Polymerase Chain Reaction Assay","volume":"51","author":"Flomenberg","year":"1997","journal-title":"J Med Virol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199702010-00015","article-title":"Detection of Adenovirus DNA by Polymerase Chain Reaction in Peripheral Blood Lymphocytes From Hiv-Infected Patients and a Control Group: Preliminary Results","volume":"14","author":"Durepaire","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2010.538079","article-title":"In Vivo and in Vitro Distribution of Type 5 and Fiber-Modified Oncolytic Adenoviruses in Human Blood Compartments","volume":"43","author":"Escutenaire","year":"2011","journal-title":"Ann Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human Erythrocytes Bind and Inactivate Type 5 Adenovirus by Presenting Coxsackie Virus-Adenovirus Receptor and Complement Receptor 1","volume":"113","author":"Carlisle","year":"2009","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1000277","DOI":"10.1371\/journal.ppat.1000277","article-title":"The Cell Adhesion Molecule \u201cCar\u201d and Sialic Acid on Human Erythrocytes Influence Adenovirus in Vivo Biodistribution","volume":"5","author":"Seiradake","year":"2009","journal-title":"PloS Pathog"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/10430340152712719","article-title":"A Pilot Study of in Vivo Liver-Directed Gene Transfer With an Adenoviral Vector in Partial Ornithine Transcarbamylase Deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum Gene Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12331","article-title":"Role of Red Blood Cells in Haemostasis and Thrombosis","volume":"12","author":"Litvinov","year":"2017","journal-title":"ISBT Sci Ser"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-3527(08)60746-0","article-title":"Virus-Erythrocyte Interactions","volume":"17","author":"Howe","year":"1972","journal-title":"Adv Virus Res"},{"key":"B33","unstructured":"Erap-Product Information, European Medicines Agency2021"},{"key":"B34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/09537100075814","article-title":"Edta-Induced Changes in Platelet Structure and Function: Adhesion and Spreading","volume":"11","author":"White","year":"2000","journal-title":"Platelets"},{"key":"B35","article-title":"Effects of Calcium and Edta on Rat Skin Capillary Permeability and on Its Response to Histamine, Serotonin and Bradykinin","volume":"39","author":"Busch","year":"1989","journal-title":"Acta Physiol Pharmacol Latinoam"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7271.1237","article-title":"The Importance of Injecting Vaccines Into Muscle. Different Patients Need Different Needle Sizes","volume":"321","author":"Zuckerman","year":"2000","journal-title":"BMJ"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPG0MNR5NGKNFX","article-title":"Platelet Factor 4\/Heparin Antibodies in Blood Bank Donors","volume":"134","author":"Hursting","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-342857","article-title":"Association of Natural Anti-Platelet Factor 4\/Heparin Antibodies With Periodontal Disease","volume":"118","author":"Greinacher","year":"2011","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02870.x","article-title":"Heparin-Induced Thrombocytopenia in Patients Requiring Prolonged Intensive Care Unit Treatment After Cardiopulmonary Bypass","volume":"6","author":"Selleng","year":"2008","journal-title":"J Thromb Haemost"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21032","article-title":"What Is the Potential for Overdiagnosis of Heparin-Induced Thrombocytopenia","volume":"82","author":"Lo","year":"2007","journal-title":"Am J Hematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01115-6","article-title":"Heterologous Prime-Boost Covid-19 Vaccination: Initial Reactogenicity Data","volume":"397","author":"Shaw","year":"2021","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in Covid-19: A Systematic Review and Meta-Analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev Med Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast Cells Signal Their Importance in Health and Disease","volume":"142","author":"Olivera","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545685","article-title":"Surmounting Limited Gene Delivery Into Primary Immune Cell Populations: Efficient Cell Type-Specific Adenoviral Transduction by Car","volume":"45","author":"Clausen","year":"2015","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.06.007","article-title":"Mast Cell Activation Syndromes","volume":"140","author":"Akin","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.trsl.2016.01.003","article-title":"Mast Cell Activation Disease and the Modern Epidemic of Chronic Inflammatory Disease","volume":"174","author":"Afrin","year":"2016","journal-title":"Transl Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","article-title":"Familial Occurrence of Systemic Mast Cell Activation Disease","volume":"8","author":"Molderings","year":"2013","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12136","article-title":"High Sensitivity and Specificity of a New Functional Flow Cytometry Assay for Clinically Significant Heparin-Induced Thrombocytopenia Antibodies","volume":"36","author":"Garritsen","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jaci.2020.05.001","article-title":"Covid-19: Unanswered Questions on Immune Response and Pathogenesis","volume":"146","author":"Maggi","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.09.016","article-title":"Covid-19 Hyperinflammation and Post-Covid-19 Illness May Be Rooted in Mast Cell Activation Syndrome","volume":"100","author":"Afrin","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.31.21255594","article-title":"Signatures of Mast Cell Activation Are Associated With Severe Covid-19","author":"Tan","year":"2021","journal-title":"medRxiv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.728513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T14:29:33Z","timestamp":1628864973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.728513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2021.728513"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.728513","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"article-number":"728513"}}